ValenTx Receives $22,000,000 Series B Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=f5c50aad-bd11-4599-966a-f3976ed97611&Preview=1 -
Date
1/5/2010 -
Company Name
ValenTx -
Mailing Address
200 Homedale Rd Carpinteria, CA 93013 -
Company Description
The company is developing less invasive treatments for morbid obesity. -
Website
http://www.valentx.com/ -
Transaction Type
Venture Equity -
Transaction Amount
$22,000,000 -
Transaction Round
Series B -
Proceeds Purposes
With this financing we will continue our Company’s development with the goal of offering a safe and effective treatment option for morbid obesity to help address the challenge this problem presents to our global community. -
M&A Terms
-
Venture Investor
SV Life Sciences -
Venture Investor
Covidien Ventures -
Venture Investor
Sapient Capital -
Venture Investor
EDF Ventures -
Venture Investor
Kaiser Permanente Ventures -
Venture Investor
Affinity Capital -
Venture Investor
TGap Ventures
